Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus

Member of:

  • Neurology


Publication year:
All
1 - 10 out of 16Page size: 10
Sort by: Title
  1. Published

    Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, Finn Thorup, Fredriksen, Jette Lautrup, Góra, M. K., Illes, Z., Kant, M., Mezei, Z., Petersen, T., Rasmussen, P. V., Roshanisefat, H., Hassanpour-Kalam-Roudy, H., Sejbæk, T., Tsakiri, A., Weglewski, Arkadiusz, Sørensen, Per Soelberg & Magyari, M., 2019, In: Neurology. 92, 16, p. e1811-e1820

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

    On behalf of the ABIRISK Consortium, O. B. O. T. A. C., Jan 2019, In: Journal of Neuroimmunology. 326, p. 19-27

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    Comi, G., Cook, S., Giovannoni, G., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Galazka, A., Nolting, A., Hicking, C. & Dangond, F., 2019, In: Multiple Sclerosis and Related Disorders. 29, p. 168-174 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

    Stuve, O., Sørensen, Per Soelberg, Leist, T., Giovannoni, G., Hyvert, Y., Damian, D., Dangond, F. & Boschert, U., 2019, In: Therapeutic Advances in Neurological Disorders. 12, p. 1-16

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., Dangond, F., Hicking, C. & Vermersch, P., May 2019, In: Multiple Sclerosis Journal. 25, 6, p. 819-827

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

    Petersen, E. R., Ammitzbøll, C., Søndergaard, H. B., Oturai, A. B., Sørensen, Per Soelberg, Nilsson, A. C., Börnsen, L., von Essen, Marina Rode & Sellebjerg, Finn Thorup, 2019, In: Journal of Neuroimmunology. 337, 577085.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

    Uccelli, A., Laroni, A., Brundin, L., Clanet, M., Fernandez, O., Nabavi, S. M., Muraro, P. A., Oliveri, R. S., Radue, E. W., Sellner, J., Soelberg Sorensen, P., Sormani, M. P., Wuerfel, J. T., Battaglia, M. A., Freedman, M. S., Bonetti, B., Rush, C., Herrera, C., Ramo Tello, C., Miller, D. & 23 others, Szwajcer, D., Strunk, D., Wall, D., Aguera-Morales, E., Rohde, E., Dazzi, F., Comi, G., Martino, G., Izquierdo Ayuso, G., Rabinovitch, H., MacLean, H., Marriott, J., Racosta, J., Arab, L., Gimona, M., Introna, M., Blinkenberg, M., Aghdami, N., Ali, R., Vosoughi, R., Nicholas, R., Marrie, R. A. & Karimi, S., May 2019, In: Trials. 20, 13 p., 263.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., Vlachos, I. S., McCabe, C., Pers, T. H., Brandes, A., White, C., Keenan, B., Cimpean, M., Winn, P., Panteliadis, I. P., Robbins, A., Andlauer, T. F. M. & 32 others, Zarzycki, O., Dubois, B., Goris, A., Søndergaard, H. B., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Ullum, H., Thørner, L. W., Saarela, J., Cournu-Rebeix, I., Damotte, V., Fontaine, B., Guillot-Noel, L., Lathrop, M., Vukusic, S., Berthele, A., Pongratz, V., Buck, D., Gasperi, C., Graetz, C., Grummel, V., Hemmer, B., Hoshi, M., Knier, B., Korn, T., Lill, C. M., Luessi, F., Karpe, F., Lage, K., Oturai, A., International Multiple Sclerosis Genetics Consortium, I. M. S. G. C. & ANZgene, IIBDGC, WTCCC2, A. I. W., 2019, In: Science. 365, 6460, eaav7188.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

    Sellebjerg, Finn Thorup, Royen, L., Sørensen, Per Soelberg, Oturai, A. B. & Jensen, P. E. H., 2019, In: Multiple Sclerosis Journal. 25, 11, p. 1444-1451 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Pulsed immune reconstitution therapy in multiple sclerosis

    Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, Mar 2019, In: Therapeutic Advances in Neurological Disorders. 12, p. 1-16

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 Next

ID: 11025